TY - JOUR
T1 - Treating the Most Vulnerable and Costly in Diabetes
AU - Wagner, David V.
AU - Stoeckel, Maggie
AU - E. Tudor, Megan
AU - Harris, Michael A.
PY - 2015/4/16
Y1 - 2015/4/16
N2 - Diabetic ketoacidosis (DKA) is associated with negative health outcomes and high costs for patients, families, and communities. Interventions developed to effectively reduce DKA and related costs should target the multiple risk factors associated with DKA and adherence difficulties. Certain demographic, psychological, and family factors are associated with increased risk for adherence problems and DKA. Individuals with a combination of risk factors (e.g., mental health problems, low socioeconomic status, high family conflict) may be particularly vulnerable to DKA. Although several different interventions have demonstrated promise in improving adherence and/or decreasing the risk of DKA, the generalizability of treatment results to those individuals most vulnerable to DKA is limited. Approaches which include multiple evidence-based components of care, are flexible in treatment delivery (e.g., home- and community-based, utilize technology), and target the multiple risk factors across relevant systems (e.g., individual, family, school, medical) are warranted to effectively reduce DKA in vulnerable populations.
AB - Diabetic ketoacidosis (DKA) is associated with negative health outcomes and high costs for patients, families, and communities. Interventions developed to effectively reduce DKA and related costs should target the multiple risk factors associated with DKA and adherence difficulties. Certain demographic, psychological, and family factors are associated with increased risk for adherence problems and DKA. Individuals with a combination of risk factors (e.g., mental health problems, low socioeconomic status, high family conflict) may be particularly vulnerable to DKA. Although several different interventions have demonstrated promise in improving adherence and/or decreasing the risk of DKA, the generalizability of treatment results to those individuals most vulnerable to DKA is limited. Approaches which include multiple evidence-based components of care, are flexible in treatment delivery (e.g., home- and community-based, utilize technology), and target the multiple risk factors across relevant systems (e.g., individual, family, school, medical) are warranted to effectively reduce DKA in vulnerable populations.
KW - Cost
KW - DKA
KW - Risk factor
KW - Treatment
KW - Type 1 diabetes
KW - Vulnerable
UR - http://www.scopus.com/inward/record.url?scp=84928243329&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84928243329&partnerID=8YFLogxK
U2 - 10.1007/s11892-015-0606-5
DO - 10.1007/s11892-015-0606-5
M3 - Review article
C2 - 25877049
AN - SCOPUS:84928243329
SN - 1534-4827
VL - 15
JO - Current Diabetes Reports
JF - Current Diabetes Reports
IS - 6
ER -